241
Participants
Start Date
September 2, 2020
Primary Completion Date
March 1, 2026
Study Completion Date
National Cancer Institute (NCI), Bethesda
University of Alabama at Birmingham, Birmingham
National Cancer Institute (NCI)
NIH